Perceived major experiences of discrimination, ethnic group, and risk of psychosis in a six-country case-control study.

Case−control discrimination first-episode minority ethnic group multi-country psychosis psychotic disorder

Journal

Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142

Informations de publication

Date de publication:
02 Mar 2021
Historique:
entrez: 2 3 2021
pubmed: 3 3 2021
medline: 3 3 2021
Statut: aheadofprint

Résumé

Perceived discrimination is associated with worse mental health. Few studies have assessed whether perceived discrimination (i) is associated with the risk of psychotic disorders and (ii) contributes to an increased risk among minority ethnic groups relative to the ethnic majority. We used data from the European Network of National Schizophrenia Networks Studying Gene-Environment Interactions Work Package 2, a population-based case-control study of incident psychotic disorders in 17 catchment sites across six countries. We calculated odds ratios (OR) and 95% confidence intervals (95% CI) for the associations between perceived discrimination and psychosis using mixed-effects logistic regression models. We used stratified and mediation analyses to explore differences for minority ethnic groups. Reporting any perceived experience of major discrimination (e.g. unfair treatment by police, not getting hired) was higher in cases than controls (41.8% v. 34.2%). Pervasive experiences of discrimination (≥3 types) were also higher in cases than controls (11.3% v. 5.5%). In fully adjusted models, the odds of psychosis were 1.20 (95% CI 0.91-1.59) for any discrimination and 1.79 (95% CI 1.19-1.59) for pervasive discrimination compared with no discrimination. In stratified analyses, the magnitude of association for pervasive experiences of discrimination appeared stronger for minority ethnic groups (OR = 1.73, 95% CI 1.12-2.68) than the ethnic majority (OR = 1.42, 95% CI 0.65-3.10). In exploratory mediation analysis, pervasive discrimination minimally explained excess risk among minority ethnic groups (5.1%). Pervasive experiences of discrimination are associated with slightly increased odds of psychotic disorders and may minimally help explain excess risk for minority ethnic groups.

Sections du résumé

BACKGROUND BACKGROUND
Perceived discrimination is associated with worse mental health. Few studies have assessed whether perceived discrimination (i) is associated with the risk of psychotic disorders and (ii) contributes to an increased risk among minority ethnic groups relative to the ethnic majority.
METHODS METHODS
We used data from the European Network of National Schizophrenia Networks Studying Gene-Environment Interactions Work Package 2, a population-based case-control study of incident psychotic disorders in 17 catchment sites across six countries. We calculated odds ratios (OR) and 95% confidence intervals (95% CI) for the associations between perceived discrimination and psychosis using mixed-effects logistic regression models. We used stratified and mediation analyses to explore differences for minority ethnic groups.
RESULTS RESULTS
Reporting any perceived experience of major discrimination (e.g. unfair treatment by police, not getting hired) was higher in cases than controls (41.8% v. 34.2%). Pervasive experiences of discrimination (≥3 types) were also higher in cases than controls (11.3% v. 5.5%). In fully adjusted models, the odds of psychosis were 1.20 (95% CI 0.91-1.59) for any discrimination and 1.79 (95% CI 1.19-1.59) for pervasive discrimination compared with no discrimination. In stratified analyses, the magnitude of association for pervasive experiences of discrimination appeared stronger for minority ethnic groups (OR = 1.73, 95% CI 1.12-2.68) than the ethnic majority (OR = 1.42, 95% CI 0.65-3.10). In exploratory mediation analysis, pervasive discrimination minimally explained excess risk among minority ethnic groups (5.1%).
CONCLUSIONS CONCLUSIONS
Pervasive experiences of discrimination are associated with slightly increased odds of psychotic disorders and may minimally help explain excess risk for minority ethnic groups.

Identifiants

pubmed: 33648622
doi: 10.1017/S0033291721000453
pii: S0033291721000453
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-9

Auteurs

Supriya Misra (S)

Department of Public Health, San Francisco State University, San Francisco, CA94132, USA.

Bizu Gelaye (B)

Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA02115, USA.

David R Williams (DR)

Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, MA02115, USA.

Karestan C Koenen (KC)

Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA02115, USA.

Christina P C Borba (CPC)

Department of Psychiatry, Boston Medical Center; Boston University School of Medicine, Boston, MA02118, USA.

Diego Quattrone (D)

Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, LondonSE5 8AE, UK.

Marta Di Forti (M)

Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, LondonSE5 8AE, UK.

Giada Tripoli (G)

Department of Experimental Biomedicine and Clinical Neuroscience, University of Palermo, 90129Palermo, Italy.

Caterina La Cascia (C)

Department of Experimental Biomedicine and Clinical Neuroscience, University of Palermo, 90129Palermo, Italy.

Daniele La Barbera (D)

Department of Experimental Biomedicine and Clinical Neuroscience, University of Palermo, 90129Palermo, Italy.

Laura Ferraro (L)

Department of Experimental Biomedicine and Clinical Neuroscience, University of Palermo, 90129Palermo, Italy.

Ilaria Tarricone (I)

Department of Medical and Surgical Science, Bologna Transcultural Psychosomatic Team, (BoTPT), Alma Mater Studiorum Università di Bologna, 40126Bologna, Italy.

Domenico Berardi (D)

Department of Biomedical and Neuro-motor Sciences, Psychiatry Unit, Alma Mater, Studiorum Università di Bologna, 40126Bologna, Italy.

Antonio Lasalvia (A)

Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Piazzale L.A. Scuro 10, 37134Verona, Italy.

Sarah Tosato (S)

Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Piazzale L.A. Scuro 10, 37134Verona, Italy.

Andrei Szöke (A)

INSERM U955, Equipe 15, Institut National de la Santé et de la Recherche Médicale, 94010Créteil, France.

Pierre-Michel Llorca (PM)

University Clermont Auvergne, CMPB CHU Clermont-Ferrand, EA7280, France.

Celso Arango (C)

Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad, Complutense, IiSGM, CIBERSAM, 28007Madrid, Spain.

Andrea Tortelli (A)

Etablissement Public de Santé Maison Blanche, 75020Paris, France.

Lieuwe de Haan (L)

Department of Psychiatry, Early Psychosis Section, Amsterdam UMC, Location: Academic, Medical Centre, University of Amsterdam, 1105AZAmsterdam, The Netherlands.

Eva Velthorst (E)

Department of Psychiatry, Early Psychosis Section, Amsterdam UMC, Location: Academic, Medical Centre, University of Amsterdam, 1105AZAmsterdam, The Netherlands.
Department of Psychiatry, Icahn School of Medicine, Mount Sinai, NY, USA.

Julio Bobes (J)

Faculty of Medicine and Health Sciences - Psychiatry, Universidad de Oviedo, ISPA, INEUROPA, CIBERSAM, 33006Oviedo, Spain.

Miguel Bernardo (M)

Barcelona Clinic Schizophrenia Unit, Hospital Clinic of Barcelona, University of Barcelona, IDIBAPS, CIBERSAM, 08036Barcelona, Spain.

Julio Sanjuán (J)

Department of Psychiatry, School of Medicine, Universidad de Valencia, Centro de, Investigación Biomédica en Red de Salud Mental (CIBERSAM), 46010Valencia, Spain.

Jose Luis Santos (JL)

Department of Psychiatry, Servicio de Psiquiatría Hospital "Virgen de la Luz,", 16002Cuenca, Spain.

Manuel Arrojo (M)

Department of Psychiatry, Psychiatry Genetic Group, Instituto de Investigación Sanitaria de, Santiago de Compostela, Complejo Hospitalario Universitario de Santiago de Compostela, 15706Santiago de Compostela, Spain.

Cristina Marta Del-Ben (CM)

Division of Psychiatry, Department of Neuroscience and Behaviour, Ribeirão Preto Medical School, University of São Paulo, São Paulo14049-900, Brazil.

Paulo Rossi Menezes (PR)

Department of Preventative Medicine, Faculdade de Medicina FMUSP, University of São Paulo, São Paulo01246-903, Brazil.

Jean-Paul Selten (JP)

Rivierduinen Institute for Mental Health Care, 2333 ZZLeiden, The Netherlands.

Peter B Jones (PB)

Department of Psychiatry, University of Cambridge, CambridgeCB2 0SZ, UK.

Hannah E Jongsma (HE)

Psylife Group, Division of Psychiatry, University College London, LondonW1T 7NF, UK.

James B Kirkbride (JB)

Psylife Group, Division of Psychiatry, University College London, LondonW1T 7NF, UK.

Bart P F Rutten (BPF)

Department of Psychiatry and Neuropsychology, School of Mental Health and Neuroscience, South Limburg Mental Health Research and Teaching Network, Maastricht University Medical Centre, 6200MDMaastricht, The Netherlands.

Jim van Os (J)

Department of Psychiatry and Neuropsychology, School of Mental Health and Neuroscience, South Limburg Mental Health Research and Teaching Network, Maastricht University Medical Centre, 6200MDMaastricht, The Netherlands.
Department of Psychosis Studies, Institute of Psychiatry, King's College London, LondonSE5 8AF, UK.

Robin M Murray (RM)

Department of Psychosis Studies, Institute of Psychiatry, King's College London, LondonSE5 8AF, UK.

Charlotte Gayer-Anderson (C)

Department of Health Service and Population Research, Institute of Psychiatry, King's College London, LondonSE5 8AF, UK.

Craig Morgan (C)

Department of Health Service and Population Research, Institute of Psychiatry, King's College London, LondonSE5 8AF, UK.

Classifications MeSH